Public IR Focus YES INTERNATIONAL specializes in disseminating information for publicly traded companies in the US, Canada, and Germany, signaling a sales opportunity to upsell investor relations and corporate communications services to small- and mid-cap listings seeking a stronger equity narrative.

Biotech Collaboration The collaboration with Atrin Pharmaceuticals on molecular diagnostics highlights demand for biotech-specific investor materials, press outreach, and regulatory disclosure support—ideal for targeting biotech and pharma clients with IR programs.

Mid-Market Growth With a mid-market client footprint, there is opportunity to offer scalable IR programs, annual report support, and ongoing market communications to similar sized public companies seeking cost-efficient, boutique IR services.

Global Reach Existing cross-border experience enables outreach to multinational clients needing coordinated cross-country investor communications, disclosure timelines, and consistency across markets.

Tech Enabled IR A robust tech stack affords scalable content distribution, collaboration, and analytics; propose a client portal, automated reporting dashboards, and secure document workflows to enhance efficiency for IR teams.